2020 ACCP Virtual Journal Club March | Real-World Data Approaches for Early Detection of Potential Safety and Effectiveness Signals for Generic Substitution:A Metoprolol Extended-Release Case Study - ON DEMAND
Real-World Data Approaches for Early Detection of Potential Safety and Effectiveness Signals for Generic Substitution: A Metoprolol Extended-Release Case Study- ON DEMAND
ACCP Virtual Journal Club Webinars
Live Session: Wednesday, March 11, 2020 from 2:00-3:00 PM ET
On Demand: March 11, 2020 to March 11, 2023
See Handouts tab for Continuing Education information on IPCE credits.
Joshua Brown, PharmD, PhD
Joshua Brown joined the Dept. of Pharmaceutical Outcomes and Policy as an assistant professor in 2016. He has experience in clinical pharmacy, health economics and outcomes research, and pharmacoepidemiology across academic, pharmaceutical industry, and managed care. His past and ongoing clinical interests have been in the cardiovascular and hematology/oncology therapeutic areas including comparative effectiveness and safety research with a focus on anti-coagulation and quality of care in thrombotic conditions such as atrial fibrillation, venous thromboembolism, and cancer. His current research program and collaborations focus on research methods for pharmacoepidemiologic and pharmacoeconomic generic and biosimilar evaluations, developing real-world evaluations of drug-drug interactions, and drug re-purposing studies (e.g. aging and Parkinson’s Disease). In 2017, Brown was named a Claude D. Pepper Junior Scholar to conduct translational research in geriatric pharmacoepidemiology and healthy aging. His academic work has been funded by the NIH, FDA, Bill & Melinda Gates Foundation, and the PhRMA Foundation in addition to contracts with pharmaceutical industry. Dr. Brown has published over 75 research articles and holds several editorial positions with high impact specialty journals in pharmacy and cardiovascular diseases and is actively involved in AMCP, ISPE, and ISPOR scientific societies. Dr. Brown was awarded as the AMCP Foundation’s “New Practitioner” for his early career contributions to managed care pharmacy and as a National Academy of Medicine Emerging Leader in 2019.
Mariam Ahmed, PhD (Moderator)
Clinical Pharmacology Reviewer
Dr. Mariam Ahmed is an early career clinical pharmacologist. She is currently a clinical pharmacology reviewer at the US Food and Drug Administration. Dr. Ahmed graduated from the University of Minnesota. Her thesis focused on applications of quantitative clinical pharmacology to rare diseases.